1923 related articles for article (PubMed ID: 16686717)
1. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
[TBL] [Abstract][Full Text] [Related]
2. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate.
Volkan T; Ihsan TA; Yilmaz O; Emin O; Selcuk S; Koray K; Bedi O
Eur Urol; 2005 Oct; 48(4):608-13. PubMed ID: 16135396
[TBL] [Abstract][Full Text] [Related]
3. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial.
Hoekstra RJ; Van Melick HH; Kok ET; Ruud Bosch JL
BJU Int; 2010 Sep; 106(6):822-6. PubMed ID: 20184573
[TBL] [Abstract][Full Text] [Related]
4. Photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia.
Fu WJ; Hong BF; Yang Y; Cai W; Gao JP; Wang CY; Wang XX
Chin Med J (Engl); 2005 Oct; 118(19):1610-4. PubMed ID: 16232345
[TBL] [Abstract][Full Text] [Related]
5. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures.
Ruszat R; Seitz M; Wyler SF; Abe C; Rieken M; Reich O; Gasser TC; Bachmann A
Eur Urol; 2008 Oct; 54(4):893-901. PubMed ID: 18486311
[TBL] [Abstract][Full Text] [Related]
6. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
[TBL] [Abstract][Full Text] [Related]
7. Predictability of irritative voiding symptoms following photoselective laser vaporization of the prostate.
Matoka DJ; Averch TD
Can J Urol; 2007 Oct; 14(5):3710-4. PubMed ID: 17949529
[TBL] [Abstract][Full Text] [Related]
8. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
Hamann MF; Naumann CM; Seif C; van der Horst C; Jünemann KP; Braun PM
Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
[TBL] [Abstract][Full Text] [Related]
9. Holmium laser prostatic resection for patients presenting with acute urinary retention.
Anderson CB; Helfand BT; McVary KT
BJU Int; 2008 Dec; 102(11):1623-8. PubMed ID: 18710443
[TBL] [Abstract][Full Text] [Related]
10. High power potassium-titanyl-phosphate laser vaporization prostatectomy.
Malek RS; Kuntzman RS; Barrett DM
J Urol; 2000 Jun; 163(6):1730-3. PubMed ID: 10799170
[TBL] [Abstract][Full Text] [Related]
11. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate.
Kumar SM
J Urol; 2005 Feb; 173(2):511-3. PubMed ID: 15643231
[TBL] [Abstract][Full Text] [Related]
12. Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL.
Pfitzenmaier J; Gilfrich C; Pritsch M; Herrmann D; Buse S; Haferkamp A; Djakovic N; Pahernik S; Hohenfellner M
BJU Int; 2008 Aug; 102(3):322-7. PubMed ID: 18422772
[TBL] [Abstract][Full Text] [Related]
13. Influence of detrusor overactivity on storage symptoms following potassium-titanyl-phosphate photoselective vaporization of the prostate.
Cho MC; Kim HS; Lee CJ; Ku JH; Kim SW; Paick JS
Urology; 2010 Jun; 75(6):1460-6. PubMed ID: 19963247
[TBL] [Abstract][Full Text] [Related]
14. Holmium laser ablation versus photoselective vaporization of prostate less than 60 cc: long-term results of a randomized trial.
Elmansy HM; Elzayat E; Elhilali MM
J Urol; 2010 Nov; 184(5):2023-8. PubMed ID: 20850828
[TBL] [Abstract][Full Text] [Related]
15. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates.
Sandhu JS; Ng C; Vanderbrink BA; Egan C; Kaplan SA; Te AE
Urology; 2004 Dec; 64(6):1155-9. PubMed ID: 15596189
[TBL] [Abstract][Full Text] [Related]
16. Influence of bladder contractility on short-term outcomes of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate.
Paick JS; Um JM; Kwak C; Kim SW; Ku JH
Urology; 2007 May; 69(5):859-63. PubMed ID: 17482922
[TBL] [Abstract][Full Text] [Related]
17. Management of lower urinary tract symptoms secondary to benign prostatic hyperplasia with open prostatectomy: results of a contemporary series.
Helfand B; Mouli S; Dedhia R; McVary KT
J Urol; 2006 Dec; 176(6 Pt 1):2557-61; discussion 2561. PubMed ID: 17085158
[TBL] [Abstract][Full Text] [Related]
18. [Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients with oral anticoagulant therapy].
Hori Y; Kuromatsu I; Sugimura Y
Hinyokika Kiyo; 2008 Oct; 54(10):651-6. PubMed ID: 19048929
[TBL] [Abstract][Full Text] [Related]
19. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia.
Ruszat R; Seitz M; Wyler SF; Müller G; Rieken M; Bonkat G; Gasser TC; Reich O; Bachmann A
BJU Int; 2009 Sep; 104(6):820-5. PubMed ID: 19239441
[TBL] [Abstract][Full Text] [Related]
20. Photoselective vaporization of the prostate: the basel experience after 108 procedures.
Bachmann A; Ruszat R; Wyler S; Reich O; Seifert HH; Müller A; Sulser T
Eur Urol; 2005 Jun; 47(6):798-804. PubMed ID: 15925076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
